Hepion Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -1,290.1% | -1,290.1% | -129.7% |
| FY2017 | -353.2% | -353.2% | -116.2% |
| FY2018 | -547.9% | -547.9% | -115.4% |
| FY2019 | -45.1% | -45.1% | -34.1% |
| FY2020 | -50.2% | -50.2% | -41.8% |
| FY2021 | -35.2% | -35.2% | -31.6% |
| FY2022 | -84.6% | -84.6% | -70.0% |
| FY2023 | -672.0% | -672.0% | -270.4% |
| FY2024 | 708.0% | 708.0% | -817.5% |
| FY2025 | -310.3% | -310.3% | -269.6% |